α-Glucosidase-IN-19
α-Glucosidase-IN-19 (Compound 6B) is a potent, orally active α-glucosidase inhibitor with an IC50 of 3.63 μM. α-Glucosidase-IN-19 shows anti-diabetic activity.
For research use only. We do not sell to patients.
- Formula: C31H25NOS
- Molecular Weight:459.60
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
α-Glucosidase-IN-19 (10 and 20 mg/kg; p.o.; once) significantly decreases the serum glucose level after the administration of glucose (3 g/kg, oral) in rats[1].
α-Glucosidase-IN-19 (2000 mg/kg; p.o.; daily, for 2 weeks) demonstrates no mortality in mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Wistar albino rats (170-200 g), Streptozotocin-induced diabetes model[1]
-
Dosage:10 and 20 mg/kg
-
Administration:Oral administration; daily, for 4 weeks
-
Result:Decreased the level of blood glucose, reversed Streptozocin-induced body weight loss. Showed antihyperlipidemic effects on Streptozotocin-induced diabetes, reduced to a significant level of serum biomarkers.
Chemical Information
-
Molecular Weight 459.60
-
Formula C31H25NOS
-
SMILES
CC1=CC=C(C=C1)C2=NC3=C(SC(C2)C4=CC=C(C=C4)/C=C/C(C5=CC=CC=C5)=O)C=CC=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)